Locally advanced NSCLC: a plea for sparing the ipsilateral normal lung-prospective, clinical trial with DART-bid (dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily) by VMAT.

Karl Wurstbauer; Margit Kazil; Marco Meinschad; Raoul Pinter; Catharina De Vries; Patrick Clemens; Christof Kreuter; Tamara Hernler; Wolfgang Hitzl; Peter Cerkl; Thomas Künzler; Alexander De Vries

doi:10.1186/s13014-022-02083-6

Locally advanced NSCLC: a plea for sparing the ipsilateral normal lung-prospective, clinical trial with DART-bid (dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily) by VMAT.

Karl Wurstbauer
, Margit Kazil
, Marco Meinschad
, Raoul Pinter
, Catharina De Vries
, Patrick Clemens
, Christof Kreuter
, Tamara Hernler
, Wolfgang Hitzl (Co-author)
, Peter Cerkl
, Thomas Künzler
, Alexander De Vries

Research Management at Paracelsus Medical University

Research output: Contribution to journal › Original Article › peer-review

4 Citations (Web of Science)

Original language	English
Pages (from-to)	120
Journal	RADIATION ONCOLOGY
Volume	17
Issue number	1
DOIs	https://doi.org/10.1186/s13014-022-02083-6
Publication status	Published - 2022

Keywords

3-DIMENSIONAL CONFORMAL RADIOTHERAPY
SIMULTANEOUS INTEGRATED BOOST
TREATMENT-RELATED PNEUMONITIS
MODULATED ARC THERAPY
CONCURRENT CHEMOTHERAPY
CANCER
CHEMORADIOTHERAPY
CHEMORADIATION
TOXICITY
ATLAS

Access to Document

10.1186/s13014-022-02083-6

Cite this

Wurstbauer, K., Kazil, M., Meinschad, M., Pinter, R., De Vries, C., Clemens, P., Kreuter, C., Hernler, T., Hitzl, W., Cerkl, P., Künzler, T., & De Vries, A. (2022). Locally advanced NSCLC: a plea for sparing the ipsilateral normal lung-prospective, clinical trial with DART-bid (dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily) by VMAT. RADIATION ONCOLOGY, 17(1), 120. https://doi.org/10.1186/s13014-022-02083-6

@article{82d93cf0878a40fdbeb55736798efb1b,

title = "Locally advanced NSCLC: a plea for sparing the ipsilateral normal lung-prospective, clinical trial with DART-bid (dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily) by VMAT.",

keywords = "3-DIMENSIONAL CONFORMAL RADIOTHERAPY, SIMULTANEOUS INTEGRATED BOOST, TREATMENT-RELATED PNEUMONITIS, MODULATED ARC THERAPY, CONCURRENT CHEMOTHERAPY, CANCER, CHEMORADIOTHERAPY, CHEMORADIATION, TOXICITY, ATLAS",

author = "Karl Wurstbauer and Margit Kazil and Marco Meinschad and Raoul Pinter and \{De Vries\}, Catharina and Patrick Clemens and Christof Kreuter and Tamara Hernler and Wolfgang Hitzl and Peter Cerkl and Thomas K{\"u}nzler and \{De Vries\}, Alexander",

note = "Hitzl: Team Biostatistics and Publication of Clincial Studies, FM\&TT, Paracelsus Medical University, Salzburg, Austria",

year = "2022",

doi = "10.1186/s13014-022-02083-6",

language = "English",

volume = "17",

pages = "120",

journal = "RADIATION ONCOLOGY",

issn = "1748-717X",

publisher = "Springer Nature",

number = "1",

}

Wurstbauer, K, Kazil, M, Meinschad, M, Pinter, R, De Vries, C, Clemens, P, Kreuter, C, Hernler, T, Hitzl, W, Cerkl, P, Künzler, T & De Vries, A 2022, 'Locally advanced NSCLC: a plea for sparing the ipsilateral normal lung-prospective, clinical trial with DART-bid (dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily) by VMAT.', RADIATION ONCOLOGY, vol. 17, no. 1, pp. 120. https://doi.org/10.1186/s13014-022-02083-6

Locally advanced NSCLC: a plea for sparing the ipsilateral normal lung-prospective, clinical trial with DART-bid (dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily) by VMAT. / Wurstbauer, Karl; Kazil, Margit; Meinschad, Marco et al.
In: RADIATION ONCOLOGY, Vol. 17, No. 1, 2022, p. 120.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Locally advanced NSCLC: a plea for sparing the ipsilateral normal lung-prospective, clinical trial with DART-bid (dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily) by VMAT.

AU - Wurstbauer, Karl

AU - Kazil, Margit

AU - Meinschad, Marco

AU - Pinter, Raoul

AU - De Vries, Catharina

AU - Clemens, Patrick

AU - Kreuter, Christof

AU - Hernler, Tamara

AU - Hitzl, Wolfgang

AU - Cerkl, Peter

AU - Künzler, Thomas

AU - De Vries, Alexander

N1 - Hitzl: Team Biostatistics and Publication of Clincial Studies, FM&TT, Paracelsus Medical University, Salzburg, Austria

PY - 2022

Y1 - 2022

KW - 3-DIMENSIONAL CONFORMAL RADIOTHERAPY

KW - SIMULTANEOUS INTEGRATED BOOST

KW - TREATMENT-RELATED PNEUMONITIS

KW - MODULATED ARC THERAPY

KW - CONCURRENT CHEMOTHERAPY

KW - CANCER

KW - CHEMORADIOTHERAPY

KW - CHEMORADIATION

KW - TOXICITY

KW - ATLAS

U2 - 10.1186/s13014-022-02083-6

DO - 10.1186/s13014-022-02083-6

M3 - Original Article

C2 - 35799182

SN - 1748-717X

VL - 17

SP - 120

JO - RADIATION ONCOLOGY

JF - RADIATION ONCOLOGY

IS - 1

ER -